Cargando…
mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition
Meningiomas (MNs), arising from the arachnoid/meningeal layer, are nonresponsive to chemotherapies, with ∼50% showing loss of the Neurofibromatosis 2 (NF2) tumor suppressor gene. Previously, we established NF2 loss activates mechanistic target of rapamycin complex 1 (mTORC1) and mechanistic target o...
Autores principales: | Beauchamp, Roberta L., Erdin, Serkan, Witt, Luke, Jordan, Justin T., Plotkin, Scott R., Gusella, James F., Ramesh, Vijaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949095/ https://www.ncbi.nlm.nih.gov/pubmed/33273014 http://dx.doi.org/10.1074/jbc.RA120.014960 |
Ejemplares similares
-
Neuregulin Promotes Incomplete Autophagy of Prostate Cancer Cells That Is Independent of mTOR Pathway Inhibition
por: Schmukler, Eran, et al.
Publicado: (2012) -
Clozapine-dependent inhibition of EGF/neuregulin receptor (ErbB) kinases
por: Kobayashi, Yutaro, et al.
Publicado: (2019) -
Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitro
por: Cardillo, Thomas M, et al.
Publicado: (2013) -
Autocrine IGF-1 Action in Adipocytes Controls Systemic IGF-1 Concentrations and Growth
por: Klöting, Nora, et al.
Publicado: (2008) -
MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R
por: Ge, Yi-Yuan, et al.
Publicado: (2014)